Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.”

60 pharma patents match "TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 60
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 60 pharmaceutical patents matching "TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

60 results for “TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.” · 30,257 patents in full index Clear search

  1. US 12279630

    Treatment and prevention of seed allergies

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  2. US 12251417

    Antimicrobial compounds from the genus Delftia

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  3. US 12134650

    Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  4. US 11933866

    Magnetic resonance maps for analyzing brain tissue

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  5. US 11892530

    Magnetic resonance maps for analyzing tissue

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  6. US 11827687

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  7. US 11820833

    Peptides that inhibit binding of EPCR to its ligand to treat inflammation

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  8. US 11617769

    Methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted
  9. US 11497793

    Compositions and methods for treating glioblastoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted
  10. US 11446323

    Compositions and methods for the treatment of fibrotic diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  11. US 11389544

    Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  12. US 11261230

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  13. US 11197907

    Antimicrobial compounds from the genus Delftia

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  14. US 11077123

    Use of bile acids and bile salts as anti bacterial agents for inhibition of bacterial conjugation and horizontal gene transfer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  15. US 10993948

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  16. US 10947509

    Cell populations, methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  17. US 10883994

    Identification of cancer stem cells markers and use of same for diagnosis and treatment

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  18. US 10809323

    Magnetic resonance maps for analyzing tissue

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  19. US 10738361

    Methods of predicting clinical course and treating multiple sclerosis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  20. US 10723780

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  21. US 10668107

    Methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  22. US 10568901

    Micro-RNA for the treatment of malignant solid tumors and metastasis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  23. US 10555963

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  24. US 10508136

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted